{"schema_version":"1","generated_at":"2026-10-28T15:47:22.160Z","data_as_of":null,"url":"https://www.findmykol.com/kol/zhaohui-jin","json_url":"https://www.findmykol.com/kol/zhaohui-jin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"zhaohui-jin","name":"Zhaohui Jin","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Mayo Clinic","institution_url":"https://www.findmykol.com/institution/mayo-clinic","city":"Rochester","state":"MN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1750659025","orcid":"0000-0001-7844-5833","openalex":"A5101829310"},"summary":"Zhaohui Jin is an Oncology physician affiliated with Mayo Clinic. OpenAlex indexes 238 publications with 4,445 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":238,"cited_by_count":4445,"h_index":30,"latest_activity_year":2024,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05037149","title":"Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Sirnaomics","source_url":"https://clinicaltrials.gov/study/NCT05037149","trial_url":"https://www.findmykol.com/trial/NCT05037149"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Exelixis Inc.","program_year":2023,"amount_usd":1695,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1750659025"},{"payer":"Daiichi Sankyo Inc.","program_year":2022,"amount_usd":1803.75,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1750659025"},{"payer":"GlaxoSmithKline, LLC.","program_year":2022,"amount_usd":1625,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1750659025"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1750659025","source":"payments"},"prescribing":{"data_year":2024,"areas_total":7,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":72.9,"classes_total":6,"classes":[{"class":"PD-1 inhibitor","setting":"administered","share_pct":21.8,"drugs":[{"name":"Pembrolizumab","share_pct":100}],"max_beneficiaries":29},{"class":"Microtubule Inhibitor","setting":"administered","share_pct":16.8,"drugs":[{"name":"Paclitaxel","share_pct":100}],"max_beneficiaries":26}]},{"area":"Metabolism & gastrointestinal","share_pct":23.1,"classes_total":4,"classes":[{"class":"Other antiemetics","setting":"administered","share_pct":18.9,"drugs":[{"name":"Fosaprepitant","share_pct":100}],"max_beneficiaries":34},{"class":"Serotonin-3 Receptor Antagonist","setting":"mixed","share_pct":4.1,"drugs":[{"name":"Palonosetron hcl","share_pct":69},{"name":"Ondansetron hydrochloride","share_pct":29.3},{"name":"Ondansetron Hcl","share_pct":1.7}],"max_beneficiaries":72}]},{"area":"Sensory organs","share_pct":3.3,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"mixed","share_pct":3.3,"drugs":[{"name":"Dexamethasone sodium phosphate","share_pct":97.4},{"name":"Dexamethasone","share_pct":2.6}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study","year":2024,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyae142","status":"verified"},{"title":"Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States","year":2024,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers16040684","status":"verified"},{"title":"Updates on the Management of Colorectal Cancer in Older Adults","year":2024,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers16101820","status":"verified"},{"title":"Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab","year":2023,"journal":"JAMA Network Open","source_url":"https://doi.org/10.1001/jamanetworkopen.2023.0400","status":"verified"},{"title":"Anti-EGFR Antibodies in the Management of Advanced Colorectal Cancer","year":2023,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyad262","status":"verified"}],"source":"works"},"contact":{"address_1":"200 1ST ST SW","city":"Rochester","state":"MN","zip":"55905","phone":"507-284-2511","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1750659025","source":"identity"},"similar":[{"name":"S Rajkumar","slug":"s-rajkumar","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/s-rajkumar","json_url":"https://www.findmykol.com/kol/s-rajkumar/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Ayalew Tefferi","slug":"ayalew-tefferi","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/ayalew-tefferi","json_url":"https://www.findmykol.com/kol/ayalew-tefferi/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-08-14","provider_certified":"2020-08-14","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}